M. Kneussl (Vienna, Austria), T. Kuriyama (Chiba, Japan)
The assessment of life expectancy of patients with primary pulmonary hypertension (PPH)
N. A. Mironova, T. V. Martynyuk, I. P. Kolos, I. E. Chazova (Moscow, Russia)
|  |
Identification of patients with systemic sclerosis at high risk of pulmonary arterial hypertension using CT scanning techniques
F. Guarasci, D. Manuel, M. Akil, C. Davies, D. Fishwick, D. Kiely, I. Armstrong, E. Van Beek (Sheffield, United Kingdom)
| |
Value of spiral computed tomography in pulmonary hypertension
B. Burakowska, K. Onish, J. Burakowski, M. Kurzyna, A. Fijalkowska, A. Torbicki, I. Bestry (Warsaw, Poland)
| |
Screening for hickman line related infection in patients with severe pulmonary hypertension
I. Armstrong, L. Martin, E. T. Taylor, D. Wooton, C. Bates, D. Kiely (Sheffield, United Kingdom)
| |
Plasma n-terminal pro-brain natriuretic peptide (NT pro-BNP) level in respiratory diseases
C. H. Hahn, Y. S. Kim, S. M. Kang, S. M. Kwak, S. K. Kim, J. Chang, S. K. Kim (Seoul, Kyunggido, South Korea)
| |
Primary pulmonary hypertension and endothelial dysfunction
T. V. Martynyuk, I. D. Konosova, N. A. Mironova, I. Y. Chazova (Moscow, Russia)
| |
Endothelial dysfunction in patients with atrial septal defect opereted upon after the age of 25
L. G. Ambatiello, V. P. Masenko, I. E. Chazova (Moscow, Russia)
| |
The application of B-type natriuretic peptide level of the dyspneic patients ; differentiation between cor pulmonale and left ventricular dysfunction
J. H. Lee, H. H. Park, I. J. Kim, D. H. Cha, S. B. Hong (Sungnam, South Korea)
| |
Pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. A case report and family screening
J. Amado, A. Caiado, P. Morgado, J. Almeida (Vila Nova de Gaia, Portugal)
| |
Diagnostic of pulmonary varicosity, another cause of coin lesion, using multi-slice technique. Demonstration of an own case
B. Wiesner, B. Rehmann, M. E. Frey (Aarau, Switzerland)
| |
Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension
J. Burakowski, M. Kurzyna, P. J. Kuca, A. Fijalkowska, B. Burakowska, W. Z. Tomkowski, A. Torbicki (Warsaw, Poland)
| |
The acute haemodynamic effects of 'pulsed' inhaled nitric oxide and iv epoprostenol in patients with pulmonary hypertension
T. Siddons, T. Higgenbottam, K. McCormack, I. Armstrong, D. Kiely (Sheffield, United Kingdom)
| |
Transition from IV to nebulised iloprost therapy as a short and long term treatment for pulmonary hypertension
I. Armstrong, F. Guarasci, L. Martin, E. A. Taylor, N. Hamilton, D. Kiely (Sheffield, United Kingdom)
| |
Assessing pulmonary vascular disease: is cardiac catheterisation a sufficiently robust gold standard?
M. A. Eneser, C. J. Emery, G. Barer, W. Wallace, T. Higgenbottam, D. Kiely, I. Armstrong (Sheffield, United Kingdom)
| |
Elevated factor FVIII:C levels in patients with pulmonary hypertension: a marked of endothelial dysfunction?
L. Martin, D. Kiely, I. Armstrong, A. Bowyer, C. Elliot, M. Makris (Sheffield, United Kingdom)
| |
Vascular damage and detection of Chlamydia spp. within endothelial cells in primary and secondary pulmonary hypertension
D. Theegarten, O. Anhenn, G. Mogilevski, K. Morgenroth (Bochum, Germany)
| |